BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Tiziana Vavalà, Alessandro Follador, Marcello Tiseo, Domenico Galetta, Alessandro Morabito, Massimo Di Maio, Olga Martelli, Orazio Caffo, Pier Luigi Piovano, D. L. Cortinovis, Nicoletta Zilembo, C. Casartelli, Giuseppe Luigi Banna, Antonio Ardizzoia, Maria Luisa Barzelloni, Alessandra Bearz, Giovenzio Genestreti, C. Mucciarini, Virginio Filipazzi, Jessica MenisElisa Rizzo, Fausto Barbieri, Erika Rijavec, F. Cecere, Emilio Bria, Gianluca Spitaleri, Antonio Rossi, Silvia Novello

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.'. Together they form a unique fingerprint.

Medicine & Life Sciences